FDA approves first Barth Syndrome treatment, Forzinity
Biospace - 21-Sep-2025Stealth BioTherapeutics wins accelerated FDA approval for its mitochondrial therapy elamipretide
Join the club for FREE to access the whole archive and other member benefits.
Known as “the powerhouse of the cell”, mitochondria generate most of the cell’s supply of adenosine triphosphate (ATP) which transports chemical energy within cells for metabolism. They are membrane-bound organelle found in most eukaryotic cells.
Stealth BioTherapeutics wins accelerated FDA approval for its mitochondrial therapy elamipretide
Funding backs trials of NRG5051, aiming to slow ALS and Parkinson’s by protecting neurons
$350K grant fuels Minovia’s biomarker work, as early trials show promising patient gains
Cell power-boosting therapy may extend healthspan by a decade beyond space missions
Click on resource name for more details.
Longevity Roadmap Podcast- Dr. Buck Joffrey and Dr. Julie Andersen explore the roots of brain disease
Live Longer World podcast- Tom Benson discusses human rejuvenation through new mitochondria
Longevity Roadmap Podcast- Mark Tarnopolsky unpacks the pivotal role mitochondria play in ageing
Reactive oxygen species (ROS) have a positive role in some processes, complicating research, but unlikely that antioxidants slow ageing
Review paper from University of Helsinki looks at the role of mitophagy in ageing